Evommune Announces Pricing of its Initial Public Offering.
Learn Here
About Us
Overview
Leadership
Collaborating
Contact
Our Science
Approach
Disease Focus
Publications & Posters
Our Pipeline
Development Pipeline
MRGPRX2 Antagonist
IL-18 Fusion Protein
Clinical Trials
Join Us
Our Culture
Job Openings
Investors & Media
Investors Overview
Company Info
Company Profile
Management Team
Presentations
Investor Contacts
FAQs
News & Events
Press Releases
IR Calendar
Email Alerts
Stock Data
Quote & Chart
Historical Data
Financials & Filings
Financial Results
All SEC Filings
Governance
Board of Directors
Board Committees
Governance Documents
Select Page
back to management
Verition Fund Management
17 of 17
17 of 17
